n-acetylsulfapyridine has been researched along with hydroxyurea in 1 studies
*Hydroxyurea: An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. [MeSH]
*Hydroxyurea: An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awni, WM; Braeckman, RA; Dubé, LM; Granneman, GR; Locke, CS | 1 |
1 trial(s) available for n-acetylsulfapyridine and hydroxyurea
| Article | Year |
|---|---|
The influence of multiple oral doses of zileuton on the steady-state pharmacokinetics of sulfasalazine and its metabolites, sulfapyridine and N-acetylsulfapyridine.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Interactions; Half-Life; Humans; Hydroxyurea; Lipoxygenase Inhibitors; Male; Middle Aged; Sulfapyridine; Sulfasalazine | 1995 |